MD Anderson Madrid – Hospiten holds an international workshop to discuss the use of HIPEC in advanced ovarian cancer Published on 15/02/2024 The meeting will be attended by the main researchers of the OVHIPEC-1(1) and CHIPOR(2) trials, randomised phase 3 studies assessing the potential efficacy of HIPEC in two specific scenarios of ovarian cancer with peritoneal carcinomatosis.